Study of ART6043 in Advanced/Metastatic Solid Tumors Patients
Status:
Not yet recruiting
Trial end date:
2026-12-14
Target enrollment:
Participant gender:
Summary
This interventional study will evaluate the safety, tolerability, pharmacokinetics, and
preliminary efficacy of ART6043 as monotherapy or in combination with Olaparib or
Talazoparib.